Tag: #LearnID
High-level Review: Updated STI Guidelines Part 2
In July 2021 the Center for Disease Control and Prevention (CDC) released their sexually transmitted infections (STI) treatment guideline, an update from 2015.1 Below, senior ID fellow Dr. Jonathan Ryder highlights significant (but by no means comprehensive) changes in this new guideline that can be incorporated into clinical practice and some of the evidence supporting these changes. Part 2 – Bacterial Vaginosis, Trichomonas, Pelvic Inflammatory Disease
Sep 7, 2021
High-level Review: Updated STI Guidelines Part 1
In July 2021 the Center for Disease Control and Prevention (CDC) released their sexually transmitted infections (STI) treatment guideline, an update from 2015.1 Below, senior ID fellow Dr. Jonathan Ryder highlights significant (but by no means comprehensive) changes in this new guideline that can be incorporated into clinical practice and some of the evidence supporting these changes. Part 1 – Chlamydia, Gonorrhea, Mycoplasma genitalium
Sep 1, 2021
In 2018, we experienced a particularly severe West Nile Virus season, with an unusually high amount of neuroinvasive disease. Last summer, our senior ID Fellow Dr. Lindsey Rearigh shared an informational blog post about the disease, and more recently, she and Dr. Sara Bares published a case report in the Journal of Neurovirology describing a […]
Mar 23, 2020
Blood culture contamination–it’s a big deal
Blood cultures are a key diagnostic test to detect bacteremia and appropriately treat patients with sepsis and are performed approximately 30 million times in the United States yearly. Unfortunately, contamination of blood cultures occurs in the 0.5% to 5% of samples (approximately 25% of positive blood cultures are due to contamination) which leads to inappropriate […]
Jan 21, 2020
PharmToExamTable: What do we know about Etravirine for HIV?
Recently, several of our HIV pharmacist colleagues in our Division of Infectious Diseases at UNMC/Nebraska Medicine, published an invited review in Clinical Pharmacokinetics entitled: Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review. The first author, Dr. Josh Havens PharmD, wrote this summary describing the review article. What prompted the review? This was an invited […]
Dec 17, 2019
Special contributor: Dr. Shipra Goel
Dr. Shipra Goel joined us for the summer as an observer in the Infectious Disease Department. We’re excited to include her contributions to our blog during the month she was with us! My journey to an exciting observership at UNMC was enabled by my passion for infectious diseases (ID) which was virulent enough to infect […]
Sep 12, 2019
Journal Club – Stewardship in Community Hospitals: How should we spend our limited resources?
Stewardship in Community Hospitals: How should we spend our limited resources? The following is a review by our ID Fellowship Program Director Dr. Trevor Van Schooneveld from our last Infection Control/Antimicrobial Stewardship Journal Club. He discussed the article by Anderson et al: Feasibility of Core Antimicrobial Stewardship Interventions in Community Hospitals. JAMA Network Open. 2019;2(8):e199369. Antimicrobial stewardship is […]
Sep 9, 2019
Treatment of Osteomyelitis – What’s the Evidence for our Strategies?
New UNMC ID publication alert! #ReadUNMCID Recently, the newest member of our Division of Infectious Diseases at UNMC/Nebraska Medicine, Dr. Nicolas Cortes-Penfield published an invited review in Open Forum Infectious Diseases entitled: The History of Antibiotic Treatment of Osteomyelitis. Dr. Cortes-Penfield wrote this summary describing the review article, which was commissioned after he published a […]
Aug 29, 2019
As we get further into the summer, we are yet again nearing West Nile Virus season, and there are starting to be a few cases reported nationwide. Our senior ID fellow Dr. Lindsey Rearigh wrote an article outlining what to expect with West Nile Virus, how it is transmitted, diagnosed, and treated. West Nile Virus […]
Aug 12, 2019
Do you really need to test the poo? Diagnostic stewardship for (outpatient) diarrheal illness
Rapid molecular testing has changed the landscape of diagnostic approaches to many infectious disease syndromes, including diarrheal illnesses. These panels typically have the capacity to diagnose multiple organisms in one test. The FilmArray gastrointestinal pathogen panel (BioFire) tests 22 stool pathogens. Despite the impact of improved clinical efficiency, these tests are often expensive, especially in […]
May 28, 2019
Recent Comments